At a glance
The March 8, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on SARS-CoV-2 variants and from the FDA and CDC Infectious Diseases Pathology Branch.
Agenda
Archived LOCS Materials Access
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
SARS-CoV-2 Variants Update: Vivien Dugan, CDC Laboratory and Testing Task Force for the COVID-19 Response
Updates from the CDC Infectious Diseases Pathology Branch: Julu Bhatnagar, CDC Division of High-Consequence Pathogens and Pathology (DCHPP)
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.